First-Line Tislelizumab Combined with Bevacizumab and CAPOX for Metastatic Gastroesophageal Adenocarcinoma with Low Programmed Death-Ligand 1 Expression
Fuente:
PubMed "industrial biotechnology"
Cancer Commun (Lond). 2026 Apr 16;46:0024. doi: 10.34133/cancomm.0024. eCollection 2026.NO ABSTRACTPMID:42007237 | PMC:PMC13084058 | DOI:10.34133/cancomm.0024